These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33792238)

  • 61. Roles of osteocytes in phosphate metabolism.
    Michigami T
    Front Endocrinol (Lausanne); 2022; 13():967774. PubMed ID: 35909535
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Klotho expression in long bones regulates FGF23 production during renal failure.
    Kaludjerovic J; Komaba H; Sato T; Erben RG; Baron R; Olauson H; Larsson TE; Lanske B
    FASEB J; 2017 May; 31(5):2050-2064. PubMed ID: 28183805
    [TBL] [Abstract][Full Text] [Related]  

  • 63. FGF23 regulation of renal tubular solute transport.
    Erben RG; Andrukhova O
    Curr Opin Nephrol Hypertens; 2015 Sep; 24(5):450-6. PubMed ID: 26125643
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In vivo evidence for a limited role of proximal tubular Klotho in renal phosphate handling.
    Ide N; Olauson H; Sato T; Densmore MJ; Wang H; Hanai JI; Larsson TE; Lanske B
    Kidney Int; 2016 Aug; 90(2):348-362. PubMed ID: 27292223
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Parathyroid hormone 1 receptor is essential to induce FGF23 production and maintain systemic mineral ion homeostasis.
    Fan Y; Bi R; Densmore MJ; Sato T; Kobayashi T; Yuan Q; Zhou X; Erben RG; Lanske B
    FASEB J; 2016 Jan; 30(1):428-40. PubMed ID: 26428657
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phosphate-sensing and regulatory mechanism of FGF23 production.
    Takashi Y; Fukumoto S
    J Endocrinol Invest; 2020 Jul; 43(7):877-883. PubMed ID: 32140858
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Phosphate homeostasis disorders.
    Christov M; Jüppner H
    Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):685-706. PubMed ID: 30449549
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Klotho Lacks an FGF23-Independent Role in Mineral Homeostasis.
    Andrukhova O; Bayer J; Schüler C; Zeitz U; Murali SK; Ada S; Alvarez-Pez JM; Smorodchenko A; Erben RG
    J Bone Miner Res; 2017 Oct; 32(10):2049-2061. PubMed ID: 28600880
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [FGF23 and osteonetwork].
    Fukumoto S
    Clin Calcium; 2016 Aug; 26(8):1143-7. PubMed ID: 27461497
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dietary phosphate supplement does not rescue skeletal phenotype in a mouse model for craniometaphyseal dysplasia.
    Liu Y; Dutra EH; Reichenberger EJ; Chen IP
    J Negat Results Biomed; 2016 Oct; 15(1):18. PubMed ID: 27784318
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.
    Gutiérrez OM
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1710-6. PubMed ID: 20507957
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism.
    Quarles LD
    Nat Rev Endocrinol; 2012 Jan; 8(5):276-86. PubMed ID: 22249518
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Regulation of phosphate transport in proximal tubules.
    Biber J; Hernando N; Forster I; Murer H
    Pflugers Arch; 2009 May; 458(1):39-52. PubMed ID: 18758808
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Molecular regulation of phosphate metabolism by fibroblast growth factor-23-klotho system.
    Cheng CY; Kuro-o M; Razzaque MS
    Adv Chronic Kidney Dis; 2011 Mar; 18(2):91-7. PubMed ID: 21406293
    [TBL] [Abstract][Full Text] [Related]  

  • 75. FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone.
    Wöhrle S; Bonny O; Beluch N; Gaulis S; Stamm C; Scheibler M; Müller M; Kinzel B; Thuery A; Brueggen J; Hynes NE; Sellers WR; Hofmann F; Graus-Porta D
    J Bone Miner Res; 2011 Oct; 26(10):2486-97. PubMed ID: 21812026
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of an oral sodium phosphate load on parathyroid hormone and fibroblast growth factor 23 secretion in normo- and hypercalciuric stone-forming patients.
    Irzyniec T; Boryń M; Kasztalska J; Nowak-Kapusta Z; Maciejewska-Paszek I; Grochowska-Niedworok E
    Clin Nutr; 2020 Dec; 39(12):3804-3812. PubMed ID: 32386861
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Parathyroid Hormone, Fibroblast Growth Factor 23, and Parameters of Phosphate Reabsorption.
    Phelps KR; Mason DL
    Am J Nephrol; 2018; 47(5):343-351. PubMed ID: 29779023
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Phosphate-Sensing.
    Takashi Y; Fukumoto S
    Adv Exp Med Biol; 2022; 1362():27-35. PubMed ID: 35288870
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Endothelin receptor B controls the production of fibroblast growth factor 23.
    Feger M; Ewendt F; Menzel M; Hocher B; Föller M
    FASEB J; 2020 May; 34(5):6262-6270. PubMed ID: 32157737
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function.
    Dhayat NA; Ackermann D; Pruijm M; Ponte B; Ehret G; Guessous I; Leichtle AB; Paccaud F; Mohaupt M; Fiedler GM; Devuyst O; Pechère-Bertschi A; Burnier M; Martin PY; Bochud M; Vogt B; Fuster DG
    Kidney Int; 2016 Sep; 90(3):648-57. PubMed ID: 27370409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.